Bard Financial Services Inc. Makes New Investment in Bath & Body Works, Inc. (NYSE:BBWI)

Bard Financial Services Inc. bought a new stake in shares of Bath & Body Works, Inc. (NYSE:BBWI) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 12,900 shares of the company’s stock, valued at approximately $412,000.

A number of other large investors have also recently modified their holdings of BBWI. True Wealth Design LLC grew its stake in Bath & Body Works by 5,270.0% in the third quarter. True Wealth Design LLC now owns 1,074 shares of the company’s stock worth $34,000 after purchasing an additional 1,054 shares during the period. Livforsakringsbolaget Skandia Omsesidigt grew its position in shares of Bath & Body Works by 300.0% in the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,200 shares of the company’s stock worth $38,000 after buying an additional 900 shares during the period. TD Private Client Wealth LLC grew its position in shares of Bath & Body Works by 24.2% in the 3rd quarter. TD Private Client Wealth LLC now owns 1,697 shares of the company’s stock worth $54,000 after buying an additional 331 shares during the period. Meeder Asset Management Inc. increased its stake in shares of Bath & Body Works by 480.3% in the 3rd quarter. Meeder Asset Management Inc. now owns 1,735 shares of the company’s stock worth $55,000 after acquiring an additional 1,436 shares in the last quarter. Finally, GAMMA Investing LLC lifted its position in Bath & Body Works by 34.4% during the 3rd quarter. GAMMA Investing LLC now owns 2,481 shares of the company’s stock valued at $79,000 after acquiring an additional 635 shares during the period. Institutional investors own 95.14% of the company’s stock.

Insider Buying and Selling at Bath & Body Works

In related news, CEO Gina Boswell purchased 6,000 shares of the business’s stock in a transaction on Wednesday, October 9th. The stock was acquired at an average price of $29.64 per share, with a total value of $177,840.00. Following the completion of the acquisition, the chief executive officer now owns 242,987 shares of the company’s stock, valued at approximately $7,202,134.68. This trade represents a 2.53 % increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. 0.27% of the stock is owned by corporate insiders.

Bath & Body Works Stock Down 0.4 %

Shares of Bath & Body Works stock opened at $38.36 on Thursday. Bath & Body Works, Inc. has a twelve month low of $26.20 and a twelve month high of $52.99. The company’s 50 day moving average is $32.26 and its 200 day moving average is $34.83. The company has a market cap of $8.31 billion, a price-to-earnings ratio of 9.36, a price-to-earnings-growth ratio of 1.37 and a beta of 1.83.

Bath & Body Works (NYSE:BBWI) last released its quarterly earnings results on Monday, November 25th. The company reported $0.49 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.46 by $0.03. The firm had revenue of $1.61 billion for the quarter, compared to the consensus estimate of $1.58 billion. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. The company’s revenue for the quarter was up 3.1% on a year-over-year basis. During the same period last year, the business posted $0.48 EPS. Sell-side analysts expect that Bath & Body Works, Inc. will post 3.26 EPS for the current fiscal year.

Bath & Body Works Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, December 6th. Investors of record on Friday, November 22nd were given a dividend of $0.20 per share. The ex-dividend date of this dividend was Friday, November 22nd. This represents a $0.80 annualized dividend and a yield of 2.09%. Bath & Body Works’s dividend payout ratio (DPR) is 19.51%.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on BBWI shares. JPMorgan Chase & Co. upped their price objective on shares of Bath & Body Works from $35.00 to $39.00 and gave the stock a “neutral” rating in a report on Tuesday, November 26th. BMO Capital Markets reaffirmed an “outperform” rating and set a $50.00 price objective (down previously from $52.00) on shares of Bath & Body Works in a research report on Thursday, August 29th. Robert W. Baird dropped their target price on Bath & Body Works from $54.00 to $45.00 and set an “outperform” rating on the stock in a report on Thursday, August 29th. Citigroup reduced their price target on Bath & Body Works from $48.00 to $35.00 and set a “neutral” rating for the company in a report on Tuesday, August 20th. Finally, Evercore ISI dropped their price target on shares of Bath & Body Works from $45.00 to $35.00 and set an “in-line” rating on the stock in a research note on Wednesday, August 28th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and nine have assigned a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $41.88.

About Bath & Body Works

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.